Higher cigarette tax clears key Hawaii Senate committee
GEORGE F. LEE / FEB. 6 The University of Hawaii Cancer Center in Kakaako.
A bill proposing a 2-cent increase in the state cigarette tax that would boost funding for the University of Hawaii Cancer Center passed its first hearing before a key Senate committee Monday despite ongoing opposition from retailers who worry about increased shoplifting and lost cigarette sales.
The latest version of House Bill 441 crossed over into the Senate at the midpoint of the legislative session and moved out of the Senate Ways and Means Committee on Monday. If approved this year and signed into law, Hawaii's per-cigarette tax would jump to 18 cents from 16 cents on Jan. 1.
The increase would go to the Hawai 'i Cancer Research special fund while simultaneously making it more expensive to buy cigarettes across the islands, with the goal of reducing cancer rates.
But UH officials have pushed back against a Senate amendment to HB 441 that would dedicate the additional 2-cent tax to reducing the cancer center's debt on capital improvement costs.
Cigarette tax revenue funded construction of the cancer center and its efforts to fight cancer, including reducing tobacco use.
'However, due to the success of smoking cessation efforts, this allocation has declined, indicating both progress in public health and a concerning decrease in resources for the initiatives that have fueled this advancement, ' according to testimony submitted to the Ways and Means Committee by Cancer Center Director Naoto Ueno and UH Manoa Provost Michael Bruno.
Don 't miss out on what 's happening !
Stay in touch with breaking news, as it happens, conveniently in your email inbox. It 's FREE !
Email 28141 Sign Up By clicking to sign up, you agree to Star-Advertiser 's and Google 's and. This form is protected by reCAPTCHA.
'Now providing less than half the funding compared with that of 2009, this source of allocation is no longer able to support its original intent to provide a top-notch facility, and to invest in the most promising cancer research, clinical care and community outreach.'
Increasing the cigarette tax to fund the cancer center has been endorsed by state agencies including the Department of Health and health organizations such as The Queen's Health Systems, Hawai 'i Public Health Institute, American Cancer Society Cancer Action Network, American Heart Association and 38 people who submitted individual testimony of support.
Opposition includes testimony from Tina Yamaki, president of the Retail Merchants of Hawaii.
She wrote that an increase in the cigarette tax would disproportionately burden lower-income smokers, 'who are already struggling with the high cost of living in Hawai 'i.'
A higher tax also could hurt small businesses, leading to job losses and potential business closures 'in an already fragile economic climate, ' Yamaki said.
They could also lose cigarette sales through increased shoplifting and from the loss of customers who might ask military friends and family to buy them tax-exempt cigarettes through Hawaii's military bases, she said.
Yamaki also criticized linking cigarette sales to fund cancer center research.
'Cigarette consumption has been steadily declining due to increased awareness and existing tax measures, ' Yamaki wrote. 'Tying funding for critical research and other special funds to an unstable revenue source creates long-term financial uncertainty for the Hawai 'i Cancer Research Special Fund. Alternative, more sustainable funding mechanisms should be considered for this or any other special fund.'
A separate Senate bill, SB 1204, would have forced the cancer center to merge with the UH medical school, which UH previously said would jeopardize the center's accreditation.
SB 1204 appears dead this session.
It represented the latest effort by state Sen. Donna Kim, who chairs the Senate Higher Education Committee, to merge the cancer center with UH's John A. Burns School of Medicine and have the center's director report to the medical school dean.
A similar bill Kim introduced in 2020 was opposed by then-UH President David Lassner.
Earlier this legislative session, new UH President Wendy Hensel told Kim and other members of the Senate Higher Education Committee that UH would return with a recommendation over whether to merge the cancer center into JABSOM.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
21 hours ago
- Newsweek
Iowa Democrat Drops Out of Senate Race, Endorses Rival
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Iowa Democratic Representative J.D. Scholten announced Monday that he is suspending his 2026 U.S. Senate campaign and endorsing fellow Democratic legislator Josh Turek in the primary race to potentially challenge Republican Senator Joni Ernst. Newsweek reached out to Scholten via email on Monday for comment. Why It Matters Scholten's endorsement consolidates Democratic support around healthcare advocacy, with Turek bringing a personal perspective to the issue. The two-time Paralympic gold medalist said his family relied on public assistance programs like Medicaid, as well as Iowa's Area Education Agencies and free summer lunch program as he was growing up, having gone through 21 surgeries by the age of 12 for spina bifida, according to his official campaign biography. The 2026 Iowa Senate race represents a critical opportunity for Democrats in a state that has shifted increasingly Republican in recent cycles. Senator Ernst's response to healthcare concerns has become a focal point for Democratic challengers seeking to make the race competitive. An important update 👉 Today I'm suspending my campaign and endorsing Josh Turek. We can't sit by while healthcare is ripped from millions of Americans and there's no better Democrat in Iowa to hold Joni to account for her cruelty than my friend fighter State Rep. Josh Turek. — J.D. Scholten (@JDScholten) August 18, 2025 What To Know Scholten, a Sioux City Democrat, entered the race in June after Ernst sparked controversy for responding to comments at a town hall about Medicaid cuts. "People are not ... well, we all are going to die," the senator said in part. Ernst's office later clarified to news outlets that she was attempting to make a broader philosophical point about mortality, not specifically about Medicaid policy. Turek, a Democrat from Council Bluffs, launched his campaign on Tuesday. The endorsement comes as both lawmakers represent western Iowa districts and share backgrounds as athletes serving in the state legislature. Scholten, a professional baseball pitcher for the minor league Sioux City Explorers, said he and Turek share many similarities as athletes representing western Iowa at the Statehouse. The Democratic primary field remains crowded despite Scholten's exit. Iowa Senator Zach Wahls, D-Coralville, Des Moines School Board Chair Jackie Norris and Nathan Sage, former Knoxville Chamber of Commerce director, are running for the seat, alongside Turek. On the Republican side, Jim Carlin, a former state lawmaker and Joshua Smith, who has run as a Libertarian candidate in previous elections, are also campaigning for the GOP nomination. Ernst has not officially said if she plans to run for reelection in 2026, though she has told reporters an announcement would be "coming soon." She also told a GOP audience last week that Democrats can "bring it on" in the 2026 election. The lawmaker has raised nearly $1.8 million in the first half of 2025 and scheduled an October fundraiser, possibly signaling preparations for a reelection campaign, the AP reports. Early polling of the race shows the senator with a slight advantage in Iowa. A June Public Policy Polling survey found that Ernst would lead a generic Democrat by about two percentage points—45 percent to 43 percent, with 12 percent still unsure. The poll did not ask voters about specific Democratic candidates. The poll surveyed 568 Iowa voters. What People Are Saying Scholten in a statement on Monday in part: "There are still so many issues facing Iowans today, but we can't sit by while healthcare is ripped from millions of Americans. And there is no better Democrat in Iowa to talk about healthcare issues than my friend: State Rep. Josh Turek." Scholten on his endorsement decision in part: "From the very beginning, I thought a prairie populist athlete from Western Iowa would be the best candidate to win in the General election. I still do, but instead of me, I have complete confidence that Josh Turek can take this on." Turek responding to Scholten's message on X: "I am honored to have the support of J.D. Over the last several years, J.D. and I have fought alongside one another in the state legislature to lower costs for Iowa's families, to make health care more affordable and accessible, to make housing more affordable, and to make life a little bit easier and a little bit better for Iowa's families." He concluded: "We have an incredible opportunity to beat Joni Ernst in 2026, and I'm proud to join forces with J.D." JD Scholten, running for congress in Iowa's 4th Congressional District against Steve King, waves to supporters outside the Wing Ding Dinner on August 9, 2019 in Clear Lake, Iowa. JD Scholten, running for congress in Iowa's 4th Congressional District against Steve King, waves to supporters outside the Wing Ding Dinner on August 9, 2019 in Clear Lake, Iowa. ALEX EDELMAN/AFP via Getty Images What Happens Next? Turek and Scholten will hold an event in Council Bluffs Monday evening. Ernst is expected to formally announce her potential reelection campaign within the coming weeks. Reporting from the Associated Press contributed to this article.
Business Upturn
a day ago
- Business Upturn
The Association for Frontotemporal Degeneration Joins Lawmakers to Advance Dementia Awareness in California
Sacramento, CA, Aug. 18, 2025 (GLOBE NEWSWIRE) — The Association for Frontotemporal Degeneration (AFTD) and FTD advocates – including Emma Heming Willis, wife of actor Bruce Willis – will travel to the California State Capitol today to mark the passage of the state's second resolution recognizing Frontotemporal Degeneration (FTD) Awareness Week. State Senator Roger Niello introduced the resolution, and will present it on the Senate floor and recognize Willis, FTD advocate Terry Walter, and their families. The resolution's coauthors in the Senate are Sens. Jones, Alvarado-Gill, Dahle, Grayson, Ochoa Bogh, Seyarto, Strickland, and Umberg. In the Assembly, its co-authors are Assemblymembers Patterson, Alanis, Chen, Irwin, and Wallis. This is the second year the AFTD and advocates have gone to California's Capitol to draw attention to the unique impacts of FTD on patients, care partners, families, and public services. In addition to increasing awareness of FTD, they called on Governor Gavin Newsom to add an FTD seat to the California Alzheimer's Disease and Related Disorders Advisory Committee. 'This resolution is a powerful step toward the awareness and policy change needed for this devastating, underdiagnosed disease,' said Meghan Buzby, AFTD's Director of Advocacy and Volunteer Engagement. 'In California, the voices of families and individuals living with FTD are resonating louder than ever — and we will continue pushing for action from the Governor and policymakers to ensure those voices drive meaningful change.' Emma Heming Willis added, 'FTD robs people of their best years and places enormous strain on care givers and families. I'm so grateful to the California Senate and Assembly for making this issue a priority and standing with us to push for change.' FTD is the most common early-onset dementia, often diagnosed in people under age 60. Symptoms include personality changes, speech difficulties, and problems with decision-making. There is no cure, but research and clinical trials offer hope. The full text of the resolution: Relative to Frontotemporal Degeneration Awareness Week. WHEREAS, It is the custom of the Legislature to recognize official weeks that are set aside to increase awareness of serious health conditions that affect the lives of citizens of California; and WHEREAS, Attendant to that concern and in full accord with its longstanding traditions, it is the sense of the Legislature to memorialize and to proclaim the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week in California, in conjunction with the observance of World FTD Awareness Week; and WHEREAS, The Association for Frontotemporal Degeneration (AFTD) reports that Frontotemporal Degeneration (FTD) is a terminal and incurable neurodegenerative disease affecting the frontal and temporal lobes, causing impairments to speech, personality, behavior, and motor skills that constitutes a major public health concern; and WHEREAS, It takes an average of 3.6 years from the initial symptoms to get an accurate diagnosis of FTD, with an average life expectancy of 7 to 13 years after the initial symptoms; and WHEREAS, FTD strikes people as young as 21 years of age and as old as 80 years of age, with the largest percentage of those affected being in their 40s to 60s, rendering people in the prime of life unable to work or function normally; and WHEREAS, FTD imposes average annual costs associated with care and living with the disease that are approximately double those of Alzheimer's disease; and WHEREAS, FTD is identified in the National Plan to Address Alzheimer's Disease as a related dementia and included as a priority in the goals and strategies of the plan to achieve the vision of a nation free of Alzheimer's disease and related dementias; and WHEREAS, The California Master Plan for Aging incorporates all 10 recommendations from the Governor's Task Force on Alzheimer's (Disease) Prevention and Preparedness to help people and families living with Alzheimer's disease and related dementia; and WHEREAS, FTD represents an estimated 5 to 15 percent of all dementia cases and is the most common form of dementia for people under 60 years of age; and WHEREAS, Approximately 40 percent of people with FTD have a family history of FTD or a related condition such as Amyotrophic Lateral Sclerosis (ALS), with about one-half of those found to have an inherited form accounted for by mutations in the Progranulin, C9orf72, Tau/MAPT and other rarer genes; and WHEREAS, FTD is often misdiagnosed as a psychiatric problem or other neurodegenerative disease because of the wide range of cognitive and behavioral symptoms and their young onset; and WHEREAS, FTD often affects a person's ability to express emotions and to show affection and empathy for loved ones; and WHEREAS, In the behavioral variant of FTD, a person's sense of social graces and appropriate behavior can be lost, and their personality may be significantly changed; and WHEREAS, Furthermore, in the language variants of FTD (primary progressive aphasia), a person may have trouble producing speech and understanding grammar, lose the meaning of words or become hesitant in their speech, and may eventually become mute; and WHEREAS, In the movement variants of FTD, a person may experience muscle weakness, falling, loss of balance, difficulty making speech, difficulty swallowing, or choking; and WHEREAS, While there has never been a global epidemiology study of FTD, it is estimated that more than 60,000 people are affected in the United States today; and WHEREAS, The AFTD is the leading national organization exclusively focused on the spectrum of FTD disorders with a mission to improve the quality of life of people affected by FTD and drive research to a cure; and WHEREAS, It is imperative that there be greater awareness of this serious disease, and more must be done to increase activity at the local, state, and national levels; now, therefore, be it Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature declares the week of September 21 to September 28, 2025, inclusive, as Frontotemporal Degeneration Awareness Week; and be it further Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution. For more information, visit Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
UPI
5 days ago
- UPI
Uruguay could become first in Latin America to pass euthanasia laws
If legislation is enacted, Uruguay would become the first country in Latin America with a law that regulates euthanasia. Photo by Lolame/ Pixabay Aug. 14 (UPI) -- Uruguay's Chamber of Deputies, the lower house of Parliament, has approved a bill on so-called "death with dignity" that would regulate euthanasia in cases of incurable illness and extreme suffering. The measure passed 64-29 and heads to the Senate. If enacted, Uruguay would become the first country in Latin America with such legislation. The bill approved by the lower house states that euthanasia may be requested only by adults with full mental capacity who have been diagnosed with a terminal, incurable and irreversible illness that causes unbearable suffering and severely diminishes their quality of life. The measure does not allow assisted suicide. Requests must be made in writing and in person. A treating physician will evaluate the case within three days, followed by an independent second opinion within five days. If the two opinions differ, a medical board will decide within an additional five days. Additionally, the proposal would create an honorary commission to review cases, oversee compliance with the procedure and report to the Health Ministry and Parliament. Violations would be subject to penalties under the Penal Code. During debate in Congress, Health Committee chairman Luis Enrique Gallo said the bill "is about love, humanity and empathy" and about people "with very serious illnesses who are suffering," as well as a Uruguay that would be "once again a leader in rights" if the legislation advances. On the other side, "Never, never can an early death be a human solution," said Deputy Rodrigo Goñi, who called the measure a "disgraceful law." "What a paradox that in the year of the bicentennial, this Parliament is writing, I would say, the saddest page in its history," he added. Parliamentary debate in Uruguay has intensified since 2019, driven by the case of former sports official Fernando Sureda, who defended his right to die with dignity after being diagnosed with amyotrophic lateral sclerosis. Polls conducted before the parliamentary debate showed strong public support for the measure. In 2020, 82% of respondents favored legalizing euthanasia, and in 2022 the polling firm Factum found 77% in support. In the Senate, the ruling Broad Front party holds a majority and is the main backer of the measure. Lawmakers are expected to pass it before the end of the year. In Latin America, the regulation of assisted dying remains largely uncharted territory, with progress driven mainly by court rulings rather than laws passed by legislatures. Colombia is the most prominent example. In 1997, the Constitutional Court decriminalized euthanasia for patients with terminal illnesses, and in 2015 it established a mandatory medical protocol. In 2022, the right was expanded to include people with serious, incurable conditions that cause intense suffering. However, legislative regulation has lagged behind, and the debate over conscientious objection and effective access remains unresolved. In 2023, Ecuador legalized euthanasia after a landmark Constitutional Court ruling in favor of Paola Roldán, a patient with ALS. The country is still working on a regulatory framework to implement the decision. Elsewhere in the region, proposals are moving forward more cautiously or face strong political and religious opposition. Chile has been debating a bill on euthanasia and medically assisted dying since 2021. The measure was approved in the Chamber of Deputies, but has stalled in the Senate due to changes in government and pressure from conservative groups. In Argentina, parliamentary debate has seen several failed attempts, though public pressure is growing after high-profile cases that highlight the lack of options for terminally ill patients. Other countries, including Mexico, Peru and Costa Rica, have introduced bills or filed court petitions seeking to recognize the right to die with dignity, but without tangible results.
